Axcella Health Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • AXLA
  • 1d-8.89%
  • 1w-15.60%
  • 1m-62.00%
  • 1y-95.11%
ATH
  • ATH Price$373.75
  • ATH Date2019-06-04
  • % since ATH-99.89%
  • % to ATH93,127.74%
ATL
  • ATL Price$0.40
  • ATL Date2023-12-29
  • % from ATL0%
  • Last Low Price$0.4009
  • Last Low Date2023-12-29
  • % From Last Low0%
IPO
  • IPO Price$15.12
  • % Current ROI USD-97.35%
  • ATH Price$373.75
  • % ROI ATH 9,322,773.76%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="AXLA"]

Key Data [addtoany]

Current price $0.4009
Sector Healthcare
Industry Biotechnology
Today's High/Low $0.5095/$0.36
Volume 6,782.00
Previous Close $0.44
52 Week High/Low $41.25/$0.34
Market Cap 1,181,716.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $-5
Annualized Dividend $0
$0.4009
[addtoany]

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. It treats complex diseases and enhances health using endogenous metabolic modulator compositions. The company’s lead product candidates include AXA1665 for the treatment of overt hepatic encephalopathy; and AXA1125 for treating non-alcoholic steatohepatitis.
It also develops AXA4010, a hematology product candidate; and AXA2678, a muscle product candidate. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity